Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study

Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease

(2021) Zhenqiu Liu et al.   DIGESTIVE AND LIVER DISEASE

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome

(2021) V. Ivashkin et al.   PLoS One

The gut vascular barrier: a new player in the gut–liver–brain axis

(2021) Paola Brescia et al.   TRENDS IN MOLECULAR MEDICINE

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

(2021) Huw Purssell et al.   World Journal of Hepatology

Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases

(2021) Yuta Matsubara et al.   NEUROPHARMACOLOGY

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

(2020) Ami D. Sperber et al.   GASTROENTEROLOGY

Global burden of irritable bowel syndrome: trends, predictions and risk factors

(2020) Christopher J. Black et al.   Nature Reviews Gastroenterology & Hepatology

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

(2020) Qing Ye et al.   Lancet Gastroenterology & Hepatology

The liver–brain–gut neural arc maintains the Treg cell niche in the gut

(2020) Toshiaki Teratani et al.   NATURE

Irritable bowel syndrome

(2020) Alexander C Ford et al.   LANCET

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

(2020) Brian E. Lacy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Myeloid cell‐specific IL‐6 signaling promotes miR‐223‐enriched exosome production to attenuate NAFLD‐associated fibrosis

(2020) Xin Hou et al.   HEPATOLOGY

Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders

(2020) Rajan Singh et al.   Journal of Neurogastroenterology and Motility

Agreement Between the Prevalence of Nonalcoholic Fatty Liver Disease Determined by Transient Elastography and Fatty Liver Indices

(2020) Gieira S. Jones et al.   Clinical Gastroenterology and Hepatology

Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts.

(2019) Margarita Papatheodoridi et al.   CURRENT PHARMACEUTICAL DESIGN

Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits

(2019) Sara G. Higarza et al.   PLoS One

A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome

(2019) Ling Zhao et al.   JOURNAL OF CLINICAL INVESTIGATION

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

The gut–liver axis and the intersection with the microbiome

(2018) Anupriya Tripathi et al.   Nature Reviews Gastroenterology & Hepatology

Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem

(2018) Åsa Frändemark et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018

(2018) Anne F. Peery et al.   GASTROENTEROLOGY

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Sex-Gender Differences in Irritable Bowel Syndrome

(2018) Young Sun Kim et al.   Journal of Neurogastroenterology and Motility

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease

(2018) David Porras et al.   Frontiers in Physiology

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome

(2016) Sean M P Bennet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines

(2015) Nadia Panera et al.   Expert Review of Gastroenterology & Hepatology

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Non-alcoholic fatty liver disease, obesity and the metabolic syndrome

(2014) Peter Dietrich et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

(2013) Antonella Scalera   WORLD JOURNAL OF GASTROENTEROLOGY

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE